In humans, the lysosomal degradation of fucosylated glycoconjugates depends on α-L-fucosidase activity, which is provided by the thoroughly characterized acidic tissue α-L-fucosidase (FUCA1) that is also involved in, for example, cancer progression and antigen processing [40,41,42]. This evidence concerns the gene FUCA1 and cancer.